Novartis AG

SWX-NOVN

Overview Financials Investor Relations Estimates Ownership Industry Dividends Modeling Filings

Income Statement	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Operating Revenues						47,498	48,659	42,781	42,206	45,440	47,546
Other Revenues, Total						1,179	1,239	1,193	1,255	1,220	1,314
Total Revenues						48,677	49,898	43,974	43,461	46,660	48,860
Total Revenues % Chg.						5.6%	2.5%	-11.9%	-1.2%	7.4%	9.7%
Cost of Goods Sold, Total						14,425	15,121	11,391	11,297	12,020	11,947
Gross Profit						34,252	34,777	32,583	32,164	34,640	36,913
Selling General & Admin Expenses, Total						14,369	14,197	12,756	12,143	12,489	12,437
R&D Expenses						9,402	8,980	8,259	8,425	9,011	8,689
Other Operating Expenses						1,395	1,448	605	387	498	1,007
Other Operating Expenses, Total						25,166	24,625	21,620	20,955	21,998	22,133
Operating Income						9,086	10,152	10,963	11,209	12,642	14,780
Interest Expense, Total						-850	-869	-787	-800	-855	-906
Interest And Investment Income						245	91	70	377	627	627
Net Interest Expenses						-605	-778	-717	-423	-228	-279
Income (Loss) On Equity Invest.						659	673	15,337	-11	-13	-40
Currency Exchange Gains (Loss)						-160	-135	-69	-184	-214	-214
Other Non Operating Income (Expenses)						-40	-34	-39	-53	17	-16
EBT, Excl. Unusual Items						8,940	9,878	25,475	10,538	12,204	14,231
Restructuring Charges	—	—	—			—	—	-827	-1,822	-951	-951
Gain (Loss) On Sale Of Investments				—	—	—	—	38	-260	-105	-218
Gain (Loss) On Sale Of Assets	—	—			—	—	—	724	166	225	225
Asset Writedown	—	—			—	—	—	-619	-1,664	-3,088	-3,288
Legal Settlements	—	—			—	—	—	-170	-313	542	1,007
Other Unusual Items					—	—	—	-91	532	296	-107
EBT, Incl. Unusual Items						8,940	9,878	24,530	7,177	9,123	10,899
Income Tax Expense						1,793	1,807	1,625	1,128	551	814
Earnings From Continuing Operations						7,147	8,071	22,905	6,049	8,572	10,085
Earnings Of Discontinued Operations			—			4,590	—	1,113	906	6,282	6,092
Minority Interest				—		-5	1	3	—	-4	-2
Net Income						11,732	8,072	24,021	6,955	14,850	16,175
Net Income to Common Incl Extra Items						11,732	8,072	24,021	6,955	14,850	16,175
Net Income to Common Excl. Extra Items						7,142	8,072	22,908	6,049	8,568	10,083
Total Shares Outstanding						2,265	2,256.8	2,234.9	2,119.6	2,044	2,024.6
Weighted Avg. Shares Outstanding						2,290.8	2,277	2,242.6	2,181.2	2,076.8	2,047.3
Weighted Avg. Shares Outstanding Dil						2,319	2,296	2,260	2,197	2,092	2,063.5
EPS						5.1	3.5	10.7	3.2	7.2	7.9
EPS Diluted						5.1	3.5	10.6	3.2	7.1	7.8
EBITDA						13,267	14,932	15,633	15,936	17,518	19,296
Effective Tax Rate						20.1%	18.3%	6.6%	15.7%	6%	7.5%